Received Sep 12, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
could not move their hand and arm; This non-serious case was reported by a consumer and described the occurrence of mobility decreased in a patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced mobility decreased (Verbatim: could not move their hand and arm). The outcome of the mobility decreased was resolved (duration 1 week). It was unknown if the reporter considered the mobility decreased to be related to Shingrix. It was unknown if the company considered the mobility decreased to be related to Shingrix. Additional Information: GSK Receipt Date: 29-AUG-2025 The reporter stated Shingrix shot was terrible. The patient could not move her/his hand and arm for a week. The patient stated still better than shingles though.